Kodiak Sciences

$113.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.82 (+6.42%) Today
$0.00 (0.00%) As of 9:25 PM UTC after-hours

Why Robinhood?

You can buy or sell KOD and other stocks, options, and ETFs commission-free!

About KOD

Kodiak Sciences Inc Common Stock, also called Kodiak Sciences, is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases.

CEO
Victor Perlroth
Employees
72
Headquarters
Palo Alto, California
Founded
2009
Market Cap
5.70B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
364.99K
High Today
$113.76
Low Today
$107.09
Open Price
$107.09
Volume
306.08K
52 Week High
$171.21
52 Week Low
$42.97

KOD Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

BFOR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure